documents: FDA-2009-P-0597-0023
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2009-P-0597-0023 | FDA | FDA-2009-P-0597 | Tab 56/Exhibit 56 - "FDA/CDER Response to Ropes & Gray (AstraZeneca,LP), November, 18, 2008, re Docket ID FDA-2006-P-0073" - [GlaxoSmithKline (Ropes & Gray LLP) - Citizen Petition] | Supporting & Related Material | CP-Citizen Petition (Supporting & Related Materials) | 2009-12-29T05:00:00Z | 2009 | 12 | 2009-12-30T00:43:08Z | 0 | 0 | 0900006480a6cd2a |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref